INTERLEUKIN LEVELS IN THE Zingiber cassumunar-TREATED MICE
DOI:
https://doi.org/10.11598/btb.0.0.0.1162Keywords:
curcumin, immunomodulator, interleukin, Zingiber cassumunarAbstract
The cytokine is one of the proteins responsible for the immune system. Several types of cytokines acting as key regulators of infection include IL-10, IL-12, and IL-14. The chemical content of Zingiber cassumunar shows potential immunomodulatory effects. This study aimed to determine the effect of the ethanol extract of Zingiber cassumunar (EEZC) on the expressions of IL-10, IL-12, and IL-14. The test animals were BALB/c mice, which were divided into five groups, i.e., normal group (untreated), negative control group (treated with 10% of tween 80), and three treatment groups that respectively received 1.25 mg, 2.5mg, and 5mg/20g BW of EEZC. The treatment was carried out for 21 days. On the 22ndday, the mice were induced with LPS intraperitoneally (except for the normal group). The interleukin expression was observed by immunohistochemistry using specific antibodies, and the expressed cells were counted under a microscope. The administration of EEZC at the doses of 1.25 mg, 2.5mg, and 5mg/20g BW for 21 days increased the expression of IL-10, IL-12, and IL-14 significantly and proportionally to the dose. and suggested the potency of extract to induce both innate and adaptive immunity. This activity may be attributable to curcumin as an active compound in this extract.Â
Downloads
Download data is not yet available.
Downloads
Published
2021-08-13
How to Cite
Mahfudh, N. (2021). INTERLEUKIN LEVELS IN THE Zingiber cassumunar-TREATED MICE. BIOTROPIA - The Southeast Asian Journal of Tropical Biology, 28(2). https://doi.org/10.11598/btb.0.0.0.1162
Issue
Section
Research Paper
License
Copyright (c) 2021 BIOTROPIA - The Southeast Asian Journal of Tropical Biology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree with the following terms:- Authors retain copyright and grant the journal right of first publication, with the work 1 year after publication simultaneously licensed under a Creative Commons attribution-noncommerical-noderivates 4.0 International License that allows others to share, copy and redistribute the work in any medium or format, but only where the use is for non-commercial purposes and an acknowledgement of the work's authorship and initial publication in this journal is mentioned.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).